If you were a 23andMe customer, your genetic and personal information could be used in civil or criminal cases, targeted ...

This means that not only does 23andMe possess the genetic data of 15 million ... For example, in 2018, 23andMe granted ...

In a live virtual event, Attaya Suvannasankha, MD, discussed the MajesTEC-1 trial of teclistamab and approaches to mitigation ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

New York-based Jones just raised $10 million to expand its nicotine lozenge company in the stodgy, $3 billion smoking ...

Me’s genetic data may be for sale after bankruptcy. AI firms may want in—but privacy fears could make it a toxic asset.

From privacy nightmares to regulatory gaps, let’s dig into the mess, the stakes, and what you can do to protect your ... data be shared with partners like GlaxoSmithKline (GSK) for drug development.

It has sold copies of its dataset to around 30, including Genentech for $65 million in 2015, and more recently, to GlaxoSmithKline ... the company was unable to do so and stopped responding ...

Sattar added, “Of course, one caveat is that we do not know the effects of this ... Carmot Therapeutics, Eli Lilly, GlaxoSmithKline, Hanmi Pharmaceutical, Janssen, Menarini-Ricerche, Merck ...

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...